Jaguar Health Advances Rare Disease Treatment Following Promising Trial Results

San Francisco, Wednesday, 19 August 2026.
Jaguar Health reported promising trial data showing its drug crofelemer reduced intravenous nutritional support by up to 48% in children with a rare disease, driving plans for a 2027 FDA submission.